Precigen Inc (PGEN)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
Apr 26, 10:13
Precigen Profit Margin (Quarterly): -2.69K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.69K% |
September 30, 2023 | -1.44K% |
June 30, 2023 | -1.15K% |
March 31, 2023 | -1.23K% |
December 31, 2022 | -1.26K% |
September 30, 2022 | |
June 30, 2022 | -605.8% |
March 31, 2022 | -349.2% |
December 31, 2021 | -679.5% |
September 30, 2021 | -893.0% |
June 30, 2021 | -525.6% |
March 31, 2021 | -70.65% |
December 31, 2020 | -215.5% |
September 30, 2020 | -125.1% |
June 30, 2020 | -142.5% |
March 31, 2020 | -187.7% |
December 31, 2019 | 41.73% |
September 30, 2019 | -293.1% |
June 30, 2019 | -118.1% |
March 31, 2019 | -268.8% |
December 31, 2018 | -1.01K% |
September 30, 2018 | -176.7% |
June 30, 2018 | -144.4% |
March 31, 2018 | -116.4% |
Date | Value |
---|---|
December 31, 2017 | -41.62% |
September 30, 2017 | -86.25% |
June 30, 2017 | -34.29% |
March 31, 2017 | -58.42% |
December 31, 2016 | -95.95% |
September 30, 2016 | -59.17% |
June 30, 2016 | -93.45% |
March 31, 2016 | -148.3% |
December 31, 2015 | -78.83% |
September 30, 2015 | -71.60% |
June 30, 2015 | -90.58% |
March 31, 2015 | 80.05% |
December 31, 2014 | 60.57% |
September 30, 2014 | -248.7% |
June 30, 2014 | -441.5% |
March 31, 2014 | 52.39% |
December 31, 2013 | -170.9% |
September 30, 2013 | |
June 30, 2013 | -89.13% |
March 31, 2013 | -934.6% |
December 31, 2012 | -475.6% |
September 30, 2012 | -700.5% |
June 30, 2012 | -606.6% |
March 31, 2012 | -859.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.69K%
Minimum
Dec 2023
41.73%
Maximum
Dec 2019
-662.6%
Average
-437.4%
Median
Profit Margin (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | -17.00K% |
HealthEquity Inc | 10.05% |
Corvus Pharmaceuticals Inc | -- |
Oragenics Inc | -- |
MAIA Biotechnology Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -64.56% |
Return on Assets | -47.63% |
Return on Invested Capital | -59.95% |
Gross Profit Margin (Quarterly) | -10.59% |
Operating Margin (Quarterly) | -1.90K% |
Return on Net Operating Assets | -92.59% |